Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
A randomized trial of amifostine and carmustine-containing chemotherapy to assess lung-protective effects
Roy B. Jones
,
Keith E. Stockerl-Goldstein
, Jared Klein
, James Murphy
, Karl G. Blume
, Roger Dansey
, Charles Martinez
, Steven Matthes
, Yago Nieto
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A randomized trial of amifostine and carmustine-containing chemotherapy to assess lung-protective effects'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Randomized Trial
100%
Chemotherapy
100%
Lung Protection
100%
Amifostine
100%
Carmustine
100%
Acute Lung Injury
40%
Stamping
40%
Lung
20%
Randomized Double-blind
20%
Placebo-controlled
20%
Hematopoietic Cell Transplantation
20%
Interim Analysis
20%
2-dose
20%
Toxic Components
20%
Chemotherapy Regimen
20%
Cytoprotection
20%
Acute Injury
20%
Cyclophosphamide
20%
High-dose Chemotherapy
20%
Cisplatin
20%
Accruals
20%
Multi-state Trials
20%
Achievable Dose
20%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Carmustine
100%
Amifostine
100%
Acute Lung Injury
28%
Placebo
14%
Cisplatin
14%
Cytoprotection
14%
Cyclophosphamide
14%
High Dose Chemotherapy
14%